BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15071929)

  • 1. [Effects of interleukin on orbital fibroblasts of patients with Graves' ophthalmopathy].
    Zhang XJ; Luo QL; Zhang MX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):241-3. PubMed ID: 15071929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on effects of interleukin-1 and their inhibitors for proliferation and hyaluronic acid synthesis of cultured human orbital fibroblasts].
    Luo Q; Zhang X
    Yan Ke Xue Bao; 2003 Dec; 19(4):232-5. PubMed ID: 14740552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an
    Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H
    Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
    Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
    J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
    Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
    Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
    Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrastructure analysis and cytokines expression of orbital fibroblasts in the patients with thyroid-associated ophthalmopathy].
    Luo QL; Zhang XJ; Zeng JH
    Zhonghua Yan Ke Za Zhi; 2003 Dec; 39(12):746-9. PubMed ID: 14769228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
    Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
    Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
    Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
    Yang S; Wang X; Xiao W; Xu Z; Ye H; Sha X; Yang H
    Front Endocrinol (Lausanne); 2022; 13():891922. PubMed ID: 35663306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of orbital fibroblasts from Graves' ophthalmopathy and healthy control.
    Wu Y; Zhang J; Deng W; Mo C; Liang Y; Huang K; Xu F; Tang F
    Heliyon; 2024 Apr; 10(7):e28397. PubMed ID: 38571651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
    Lou H; Wu LQ; Wang H; Wei RL; Cheng JW
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):18. PubMed ID: 34546326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins.
    Krieger CC; Neumann S; Place RF; Marcus-Samuels B; Gershengorn MC
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1071-7. PubMed ID: 25485727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    Choi YJ; Kim C; Choi EW; Lee SH; Chae MK; Jun HO; Kim BY; Yoon JS; Jang SY
    PLoS One; 2022; 17(8):e0270416. PubMed ID: 35980936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist ribonucleic acid and protein expression by cultured Graves' and normal orbital fibroblasts is differentially modulated by dexamethasone and irradiation.
    Mühlberg T; Joba W; Spitzweg C; Schworm HD; Heberling HJ; Heufelder AE
    J Clin Endocrinol Metab; 2000 Feb; 85(2):734-42. PubMed ID: 10690884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection, localization and modulation of hyaluronic acid/CD44 receptor expression in patients with endocrine orbitopathy].
    Heufelder AE; Bahn RS; Boergen KP; Scriba PC
    Med Klin (Munich); 1993 Apr; 88(4):181-4, 277. PubMed ID: 8492772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of hyaluronan synthesis by interleukin-1beta involves activation of protein kinase C betaII in fibroblasts from patients with Graves' ophthalmopathy.
    Wong YK; Tang KT; Wu JC; Hwang JJ; Wang HS
    J Cell Biochem; 2001 Apr 2-27; 82(1):58-67. PubMed ID: 11400163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy.
    Tan GH; Dutton CM; Bahn RS
    J Clin Endocrinol Metab; 1996 Feb; 81(2):449-52. PubMed ID: 8636247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.